The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer

BACKGROUND: The hypoxia marker pimonidazole is a candidate biomarker of cancer aggressiveness. We investigated the transcriptional programme associated with pimonidazole staining in prostate cancer. METHODS: Index tumour biopsies were taken by image guidance from an investigation cohort of 52 patien...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Br J Cancer
Hoofdauteurs: Ragnum, H B, Vlatkovic, L, Lie, A K, Axcrona, K, Julin, C H, Frikstad, K M, Hole, K H, Seierstad, T, Lyng, H
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2015
Onderwerpen:
Molecular Diagnostics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453458/
https://ncbi.nlm.nih.gov/pubmed/25461803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.604
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items